01:00:38 EDT Fri 17 May 2024
Enter Symbol
or Name
USA
CA



Alpha Cognition Inc
Symbol ACOG
Shares Issued 108,902,455
Close 2023-12-14 C$ 0.61
Market Cap C$ 66,430,498
Recent Sedar Documents

Alpha Cognition hires Planet for IR services

2023-12-15 12:42 ET - News Release

Mr. Michael McFadden reports

ALPHA COGNITION ANNOUNCES ENGAGEMENT OF INVESTOR RELATIONS SERVICE PROVIDER

Alpha Cognition Inc. has entered into an agreement with Planet Ventures Inc. dated Dec. 13, 2023, for the provision of investor relations and communication services to the company.

Pursuant to the terms and conditions of the agreement, Planet has agreed to provide the company with public relations and marketing services, among other things, in an effort to increase public awareness of the company. The services may be delivered in a variety of mediums through different platforms, including but not limited to social media and industry-related platforms. The agreement is for a term commencing on Dec. 20, 2023, and expiring on Dec. 30, 2024. In accordance with the terms and conditions of the agreement and as consideration for its services, the company will pay Planet a one-time cash fee of $160,000.

Planet is a Vancouver-based investment issuer that trades on the TSX Venture Exchange under the symbol PXI. In addition to its wholly owned subsidiaries and investment portfolio, Planet assists micro-, small- and mid-cap public companies with market awareness campaigns; it helps them gain valued industry exposure through its large network of licensed advisers and institutional investors. Planet operates as an arm's-length service provider to the company and is not entitled to receive any securities of the company in connection with this engagement. Planet's business is located at suite 303, 750 West Pender St., Vancouver, B.C., V6C 2T7. and Planet can be contacted at info@planetventuresinc.com and 604-681-0084.

About Alpha Cognition Inc.

Alpha Cognition is a clinical-stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and cognitive impairment with mild traumatic brain injury (mTBI), for which there are currently no approved treatment options.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.